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eports of travellers with clinical and epidemiological diag-
osis of NWCL, assisted from 1994 through 2008.
Results: 39 cases of NWCL were recorded (29 males, 10
emales, with age ranged from 17 to 72 years). Twenty-nine
74%) patients were residents of Argentina, 10 (26%) were
oreigners in transit. The reason for travel was tourism in 21
54%), work 14 (36%) and friends and relatives visit (VFR) 4
10%).
26 patients (67%) acquired the disease outside Argentina;
3 (33%) in Argentina, who were domestic travelers to
ndemic areas.
At query time 16 (41%) patients had lesions 30 to 60 days
f development, 19 (49%) 75 to 120 days.
Estimated average time of exposure in risk area was 20
ays.
Thirty patients (77%) had multiple lesions and 9 (23%) had
ingle lesion.
84.61% of the lesions were ulcers; 67% of the lesions were
ocalized in the extremities, 23% of the face and 10% in
runk.
The diagnosis was made by direct microscopic examina-
ion in 29 (74%), and 10 (26%) by biopsy, 7 were cultured
5 were positive). No species identiﬁcation was made in
ither case. 36 patients received as ﬁrst treatment sched-
le meglumine antimoniate intramuscular (20mg/kg/day
or 21 days), 2 patients amphotericin B deoxycholate
.5mg/kg/day up to 1,5 grams total and 1 patient who trav-
lled around Panama received ﬂuconazole 200mg/day for 6
eeks. 4 patients treated with meglumine antimoniate had
dverse effects.
85% of patients cured with ﬁrst therapeutic regimen.
3 patients treated with antimonials reported relapses,
ne patient had therapeutic failure. All healed without sub-
equent relapse.
Conclusion: Cutaneous leishmaniasis is a risk for travelers
o tropical areas of America and is necessary to include pre-
ention guidelines in pre travel advisory. It is important that
hysician be trained in the recognition of this condition and
onsider the possibility of mucosal involvement in patients
nfected with L braziliensis.
oi:10.1016/j.ijid.2010.02.1797
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Background: Malaria is the most important parasitic
nfection that produces human disease. It is caused by pro-
ozoa of the genus Plasmodium and transmitted by the bite
f the female Anopheles mosquito. It’s endemic in over 90
ountries and is the most common speciﬁc etiologic diagno-
is in febrile travelers.
Methods: A retrospective, cross-sectional and descriptive
nalysis was performed based on medical reports of trav-
o
m
c
v
tternational Congress on Infectious Diseases (ICID) Abstracts
llers with diagnosis of imported malaria, assisted from 1981
hrough 2008.
Results: Of 1010 returned travelers (domestic and inter-
ational) seen at our clinic, 337 (36.36%) patients cited fever
s a chief reason for seeking care and 143 (42.43%) of them
ad malaria.
There were 135 (94.40%) cases of imported malaria, 100
74.07%) males and 35 (25.92%) females, from 3 to 73 years.
27 (94.07%) travelers were residents.
The species involved was P. vivax in 61 cases (46.18%), P.
alciparum in 59 (43.70%); P.ovale in 1 (0.74%), mixed infec-
ions of P. falciparum and vivax malaria in 3 (2.22%) and 11
ases (8.14%) without identiﬁcation.
74 (54.81%) travelers acquired malaria in Africa, 48
35.55%) in South America, and 7 (5.18%) in Central America.
The reasons for travel were: 56 (41.48%) work/business;
7 (34.81%) tourism; 18 (13.33%) visiting friends and rela-
ives; 13 (9.62%) missionary/volunteer; and 1 (0.74%) per
ducation. In travelers to Africa the species most frequently
nvolved was P. falciparum (52/74, 70.27%) and P. vivax in
outh America (38/48, 79.16%).
Only 40 (2.96%) travelers received medical advice before
he trip, of them 32 (80%) received chemoprophylaxis for
alaria, 3 (9.37%) of which were inappropriate according
o the area visited. None of the chemoprophylaxis included
rimaquine. All patients improved with treatment. 5 / 59
8.47%) travelers had P. falciparum severe malaria.
Conclusion: In febrile returned traveler, we must always
onsider the diagnosis of malaria regardless of the time
lapsed since leaving the malaria area. Plasmodium fal-
iparum malaria is a medical emergency. The treatment
epends on the knowledge of the geographical distribution
f parasite resistance against antimalarial drugs, especially
hen no parasite species identiﬁcation is possible.
It should be emphasized prevention with personal pro-
ection measures and adequate chemoprophylaxis.
oi:10.1016/j.ijid.2010.02.1798
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Background: Travel Medicine Working Group (TMWG),
stablished in 1992, is the ﬁrst program for prevention
f travel medicine related infectious diseases in Buenos
ires. TMWG aims to improve travelers health and to raise
wareness of its importance to the argentinean public. The
bjective of this presentation is to describe the scope of a
ultidisciplinary TMWG.
Methods: TMWG comprises infectious diseases spe-
ialists, high-tech, up-to-date laboratory facilities and
accination centers. We designed a program aimed to assist
ravellers before departure, en route, after return and to
